Syal, C., Kosaraju, J., Hamilton, L., Aumont, A., Chu, A., Sarma, S. N., . . . Wang, J. (2020). Dysregulated expression of monoacylglycerol lipase is a marker for anti-diabetic drug metformin-targeted therapy to correct impaired neurogenesis and spatial memory in Alzheimer's disease. Theranostics.
Chicago ZitierstilSyal, Charvi, et al. "Dysregulated Expression of Monoacylglycerol Lipase Is a Marker for Anti-diabetic Drug Metformin-targeted Therapy to Correct Impaired Neurogenesis and Spatial Memory in Alzheimer's Disease." Theranostics 2020.
MLA ZitierstilSyal, Charvi, et al. "Dysregulated Expression of Monoacylglycerol Lipase Is a Marker for Anti-diabetic Drug Metformin-targeted Therapy to Correct Impaired Neurogenesis and Spatial Memory in Alzheimer's Disease." Theranostics 2020.